Results 151 to 160 of about 879,926 (306)
Hypertension and cardiac arrhythmias [PDF]
Lip, Gregory Y H, Coca, Antonio
openaire +2 more sources
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
Connective tissue disorders and cardiac arrhythmias: genetic pathways, mechanistic bridges, and clinical implications. [PDF]
Dreher L +9 more
europepmc +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Cardiac arrhythmias associated with S1PRMs: a pharmacovigilance study based on real-world data. [PDF]
Wang S, Xie L, Ma P.
europepmc +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Massive Bochdalek Hernia in an Adult Presenting With Cardiac Arrhythmias: A Case Report. [PDF]
Rodriguez EA +2 more
europepmc +1 more source
Cardiac arrhythmias are among the most complex cases facing any clinician. While the field appears well defined and structured, the range of possible arrhythmias, how they are identified and how they should be managed are open to infinite variations that
Rolley, Adam
core
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source

